Tag: bascom palmer to host amd clinical trials

Bascom Palmer Eye Institute has received IRB (institutional review board) approval for becoming the third clinical testing site in the U.S. for Advanced Cell Technology’s (ACT) embryonic stem cell-derived retinal pigment epithelial cells in treating dry age-related macular degeneration. Bascom Palmer Eye Institute, located in Miami and voted eight years in a row as the […]